← All organizations
Highest phase reached
Phase 3
First clinical trial
Sep 1, 2017Last known activity
Sep 30, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (3 distinct, 3 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Indications
Recent trials (3)
- NCT05327894Overall official - principal investigatorPhase 3Sep 30, 2022
- NCT04925609Overall official - principal investigatorPhase 1/Phase 2Dec 31, 2021
- NCT03590171CollaboratorPhase 2Sep 1, 2017
Details
- Last known activity
- Sep 30, 2022